Tmod-29. glioblastoma patient-derived xenograft microtumors as a high throughput preclinical testing platform

CONCLUSION:GBM PDX microtumors are well suited to high throughput therapeutic testing.

Source: Neuro-Oncology - November 6, 2016 Category: Cancer & Oncology Authors: Willey, C., Gillespie, Y., Anderson, J., Langford, C., Gilbert, A., Hicks, P., Shevin, R., Singh, R. Tags: TUMOR MODELS Source Type: research